14th Jul 2015 08:34
LONDON (Alliance News) - Lifeline Scientific Inc Tuesday said it has won contracts in North America, Europe and the Middle East, which combined are expected to contribute in excess of USD1.2 million in annual revenue.
In the US, the transplantation technology company said it has received a significant order for LifePort Kidney Transporters, related consumables and preservation solutions from the Birmingham, Alabama-based regional transplant programme. The programme recovers up to 250 donor kidneys for transplant annually and it is expected that LifePort will be employed in most of these procedures, Lifeline said. Total revenue from the region is anticipated to exceed USD0.8 million during the next 12 months.
Meanwhile in France, Lifeline said it has received new orders to supply LifePort Kidney Transporters and related consumables to additional renal transplant programmes in Paris, Nancy, Metz and Montpellier, taking the number of LifePort exclusive sites to 32 of the 34 transplant programmes in France. The transplant programme in the French territory of Guadeloupe also acquired four LifePorts.
Switzerland's Bern-based national transplant agency, Swisstransplant, has also placed initial orders for LifePort Kidney Transporters and related consumables, with 12 LifePorts available in six transplant centres, while new transplant centre accounts were opened in Spain, Austria and Saudi Arabia.
"Further adoption and use of LifePort within our home US market is anticipated and we are grateful for the opportunity to serve Alabama which is one of America's premier transplant programmes. We are also seeing wider adoption of LifePort in key centres of Europe and the Middle East, and these latest orders are further evidence of this progress. As LifePort's clinical benefits become better understood within the worldwide transplant community, we are encouraged that continued growth in LifePort's adoption as the standard of care for machine preservation of donor kidneys can be realised," Chief Executive David Kravitz said in a statement.
Shares in Lifeline were trading down 1.3% at 195.00 pence Tuesday morning.
By Karolina Kaminska; [email protected] @KarolinaAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
LSIC.L